basal insulin and glp 1 It might be the era of GLP-1 RA, but is still the resort when plan goes sideways Current Insights, Advantages and Challenges

The clearance is still slow and controlled enough to provide sustained benefits all week long

Understanding how these medications work - and what happens when treatment ends - can help patients create a smarter long-term strategy for weight management

Anxiety on tirzepatide and muscle pain with tirzepatide have also been reported, though these are less common

These numbers are substantial and could greatly impact how rheumatologists and physicians address cardiovascular risk in patients with autoimmune conditions

Moreover, improvements in cardiac function resulting from treatment with GLP-1 receptor agonists may also contribute to the favorable kidney outcomes seen with these treatments by improving tissue perfusion (20)

You should never stop medication without consulting your provider first